Follow The Filings

EXPO Exponent

Exponent earnings company data as of 9:59 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 0.60 — —
Rev — — —

Insider trades

Open-market buys and sales by EXPO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EXPO insider trades
  • $13K bought by 1 insider
  • $795K sold by 5 insiders outside a trading plan
  • $2.2M sold by 1 insider under 10b5-1 plans
  1. Shukri Jeries Souri Group Vice President
    Buy
    $13K 184 shares at $68.45 +0.5% to stake
    Traded Sep 18 Filed Sep 22
    ↗
  2. Catherine Corrigan CEO
    Planned sale
    $113K 1,707 shares at $66.28 1.3% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  3. Catherine Corrigan CEO
    Planned sale
    $109K 1,737 shares at $62.78 1.5% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  4. Catherine Corrigan CEO
    Planned sale
    $235K 4,119 shares at $57.13 3.7% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  5. Bradley A James Group Vice President
    Sale
    $115K 2,000 shares at $57.47 64% of stake
    Traded May 26 Filed May 27
    ↗
  6. Richard Reiss Group Vice President
    Sale
    $98K 1,672 shares at $58.65 42% of stake
    Traded May 19 Filed May 19
    ↗
  7. Catherine Corrigan CEO
    Planned sale
    $227K 4,194 shares at $54.06 3.8% of stake
    Traded May 15 Filed May 15
    ↗
  8. Joseph Rakow Group Vice President
    Sale
    $161K 2,945 shares at $54.66 100% of stake
    Traded May 13 Filed May 13
    ↗
  9. Joseph Sala Group Vice President
    Sale
    $117K 2,066 shares at $56.66 100% of stake
    Traded May 13 Filed May 13
    ↗
  10. Catherine Corrigan CEO
    Planned sale
    $529K 7,821 shares at $67.59 7% of stake
    Traded Mar 16–Apr 15 Filed Apr 16
    ↗
  11. Catherine Corrigan CEO
    Planned sale
    $263K 3,920 shares at $67.15 4% of stake
    Traded Feb 17 Filed Feb 18
    ↗
  12. John Pye VP Global Offices & Innovation
    Sale
    $304K 4,000 shares at $75.97 14% of stake
    Traded Feb 10 Filed Feb 12
    ↗
  13. Catherine Corrigan CEO
    Planned sale
    $121K 1,663 shares at $72.52 1.8% of stake
    Traded Jan 15 Filed Jan 20
    ↗
  14. Catherine Corrigan CEO
    Planned sale
    $228K 3,225 shares at $70.74 3.7% of stake
    Traded Dec 15, 2025 Filed Dec 16, 2025
    ↗
  15. Catherine Corrigan CEO
    Planned sale
    $345K 4,900 shares at $70.39 5.5% of stake
    Traded Nov 17, 2025 Filed Nov 18, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 33 option exercises, 8 share withholdings for taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.